Neurodevelopmental Disorders D065886

Psychiatry and Psychology [F] » Mental Disorders [F03] » Neurodevelopmental Disorders

Description

These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).   MeSH

Subtype Terms (14)

Anxiety, Separation
9 approved drugs

Attention Deficit and Disruptive Behavior Disorders
60 drugs (36 approved, 24 experimental)

Child Behavior Disorders
2 approved drugs

Child Development Disorders, Pervasive
14 drugs (12 approved, 2 experimental)

Communication Disorders
2 drugs (1 approved, 1 experimental)

Developmental Disabilities
7 drugs (6 approved, 1 experimental)

Intellectual Disability
34 drugs (25 approved, 9 experimental)

Learning Disabilities
8 drugs (6 approved, 2 experimental)

Motor Skills Disorders
 

Mutism
1 approved drug

Reactive Attachment Disorder
 

Schizophrenia, Childhood
2 approved drugs

Stereotypic Movement Disorder
 

Tic Disorders
13 drugs (7 approved, 6 experimental)


Phase 1 Indicated Drugs (1)

Other Experimental Indicated Drugs (3)


Organization Involved with Phase 1 Indications (2)

Hierarchy Tree View


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.